Press Releases

Press Releases

03.01.21
OpGen Wins Chinese NMPA Approval for the Curetis Unyvero System
02.16.21
OpGen Subsidiary Ares Genetics Announces Publication of Study Introducing Best Practice Techniques for AI-powered Prediction of Antibiotic Susceptibility Testing by Next-Generation Sequencing
02.09.21
OpGen, Inc. Announces $25 Million Registered Direct Offering Priced At-the-Market Under NASDAQ Rules
01.13.21
OpGen Announces Preliminary Unaudited Revenue for Fiscal 2020 and Provides Business Update
01.05.21
OpGen Subsidiary Curetis and Annar Enter into Unyvero Distribution Partnership for Colombia
12.17.20
Results from 1,400 Patient Sample Multicenter Study Published: Unyvero LRT BAL Panel Provides Accurate Detection in Bronchoalveolar Lavage Fluid, Allowing Enhanced Diagnosis of Lower Respiratory Tract Infections
12.09.20
OpGen Announces Planned Leadership Transition at Next Generation Sequencing and Bioinformatics Subsidiary Ares Genetics
12.01.20
OpGen Group Company Ares Genetics Advances ares-genetics.cloud Platform, Presents Update at Scientific Conferences, Expects Granting of Key Patent
11.24.20
OpGen, Inc. Announces $10 Million Private Placement Priced at the Market
11.12.20
OpGen Group Company Ares Genetics Commercially Launches NGS-based Antibiotic Resistance Testing Service for Native Specimens and Receives Bulk Order from Public Health Agency